Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Nvidia’s Cash Machine Fuels Buybacks, Investments — and Debt

Nvidia long-term debt quadrupled to $32.4 billion. Here's how the chipmaker is funding massive buybacks and AI investments. The post Nvidia’s Cash Machine Fuels Buybacks, Investments — and Debt appeared first on Global Finance Magazine .

Nvidia’s Cash Machine Fuels Buybacks, Investments — and Debt

Nvidia, the Santa Clara, California-based chipmaker, continues to deploy record cash flow towards stock buybacks, investments, and accruing debt. In the third quarter of 2025, the company reported $115.8 billion in revenue, a 103% increase year-over-year and 20% increase from the prior quarter. However, inventory rose 86% and long-term debt more than quadrupled since January.

Nvidia's newest AI computing platform, Vera Rubin, has seen explosive growth, but the company is struggling with receivables doubling to $81 billion, tying up roughly 64 days of quarterly revenue in unpaid invoices. The company's accounts payable has more than doubled to $21.1 billion, with accrued and other current liabilities reaching $33.3 billion.

Despite these challenges, Nvidia's operating cash flow remains strong at $48.3 billion, double the year-earlier figure, and free cash flow reached $43.8 billion. However, the company faces significant risks due to heavy customer concentration, with three unnamed direct customers accounting for 44% of revenue in the first half of the fiscal year.

Additionally, Nvidia has made numerous strategic investments, spending $15.7 billion on equity securities and $2.7 billion on acquisitions, leading to net gains on equity securities falling to $1.8 billion. While Nvidia has returned $28.1 billion to shareholders in the form of share repurchases and dividends, which constitute about 64% of free cash flow, analysts warn of potential risks if customers pause orders, switch to in-house chips, or pay late, potentially causing significant revenue and cash flow problems for the company.

Written by urgent.news from Global Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at gfmag.com →

More in Finance & Markets

Lilly Buying Spree Surpasses $32B

Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.” Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32…

More from Wednesday 18 November →